Join us for the 21st Annual Cardiometabolic Health Congress (CMHC), building on over two decades of leadership in cardiometabolic health education. From October 15-17, 2026, with a pre-conference on October 14, at the Boston Park Plaza, this premier event will unite healthcare providers from around the globe to transform cutting-edge research into actionable strategies that […]
The Advanced Advocacy Academy (A3) was created to close a critical gap in the liver community: patients and caregivers needed the skills, knowledge, and confidence to advocate effectively—and to help drive meaningful change in healthcare. A3 equips advocates with practical training in communication, policy engagement, and strategic storytelling so they can influence decisions that impact […]
MASLD/NAFLD & Metabolic Liver Disease MASLD/NAFLD & Metabolic Liver Disease encompasses a spectrum of liver disorders driven primarily by metabolic dysfunction, including obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, and sedentary lifestyle. Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is now the most common chronic liver condition globally […]
